<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04935970</url>
  </required_header>
  <id_info>
    <org_study_id>16-19</org_study_id>
    <nct_id>NCT04935970</nct_id>
  </id_info>
  <brief_title>Metabolic Disorders and Vertigo</brief_title>
  <official_title>Metabolic Disorders and Their Correction in Vertigo and Unsteadiness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>I.M. Sechenov First Moscow State Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>I.M. Sechenov First Moscow State Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D,&#xD;
      homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and&#xD;
      central origin (vestibular migraine). Also we will analyse another factors (such as anxiety&#xD;
      and depression) and optimize therapeuthical approach accordingly with the data.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dizziness causes up to 2 to 15% of primary neurological complaints. In some patients who have&#xD;
      undergone acute vertigo, postural instability, persistent postural perceptual vertigo (PPPV)&#xD;
      develops, while in other similar cases occurs full recovery. So, it is necessary to search&#xD;
      for neurophysiological, metabolic and psychophysiological factors and associated premorbid&#xD;
      conditions that affect the outcome of neurovestibular compensation.&#xD;
&#xD;
      The case-control study will include 2 groups of patients suffering from vertigo of central&#xD;
      and peripherial etiology. First group is recruited with patients were diagnosed with&#xD;
      peripherial vestibular disorders, such as benign paroxysmal positional vertigo (BPPV),&#xD;
      Meniere disease, vestibular neuritis. The proposal number of subjects in the first group is&#xD;
      about forty. The second group will consist of forty patients with central vestibular&#xD;
      disfunction: vestibular migraine, central positional vertigo etc. The inclusion of patient&#xD;
      with persistent postural perceptual dizziness is discussed. Patients will be tested for&#xD;
      hydroxyvitamin D and homocysteine in serum using an enzyme-linked immunosorbent assay&#xD;
      (ELISA). The perception of the severity of disability was assessed using the Dizziness scale&#xD;
      Handicap Inventory (DHI). All patients will undergo psychological test, including tas-26&#xD;
      scale, Beck's Depression Inventory, Spielberg-Hanin'sscale. Statistical analysis was carried&#xD;
      out with the Statistical Analysis System (SAS) package. The relationships will be assessed&#xD;
      using the chi squared test and logistic regression. The level of significance is set at p &lt;&#xD;
      0.05. The methods for small samples (Mann-Whitney U ) will be used. It is presumed that&#xD;
      differences in vitamin D levels beetween two groups will be considerable.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>vitamin D deficiency/insufficiency reveal</measure>
    <time_frame>Through 1-6 months of diagnosis established.</time_frame>
    <description>enzyme-linked immunosorbent assay (ELISA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hyperhomocysteinaemia reveal</measure>
    <time_frame>Through 1-6 months of diagnosis established.</time_frame>
    <description>enzyme-linked immunosorbent assay (ELISA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between metabolic and neuropsychological disorders</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Benign Paroxysmal Positional Vertigo (BPPV)</condition>
  <condition>Vestibular Migraine</condition>
  <condition>Central Positional Vertigo</condition>
  <condition>Vestibular Neuritis</condition>
  <condition>Meniere Disease</condition>
  <arm_group>
    <arm_group_label>patients with peripherial vestibular disorder</arm_group_label>
    <description>Forty patients with BPPV, vestibular neuritis or another peripherial vestibular disorder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with central vestibular disorder</arm_group_label>
    <description>Forty patients vestibular disorder of central origin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <description>twenty healthy control without balance problems</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>diagnostic blood test</intervention_name>
    <description>vitamin D deficiency/insufficiency reveal, hyperhomocysteinaemia reveal</description>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_label>patients with central vestibular disorder</arm_group_label>
    <arm_group_label>patients with peripherial vestibular disorder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>neuropsychological test</intervention_name>
    <description>neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.</description>
    <arm_group_label>patients with central vestibular disorder</arm_group_label>
    <arm_group_label>patients with peripherial vestibular disorder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients from clinic with damage of peripheral and central origin&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent of participation in the study;&#xD;
&#xD;
          -  Age:over 18 years old&#xD;
&#xD;
          -  complaints of dizziness and insteadiness&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cognitive impairment (dementia)&#xD;
&#xD;
          -  Severe depression&#xD;
&#xD;
          -  Syncopal paroxysms&#xD;
&#xD;
          -  Epileptic seizures&#xD;
&#xD;
          -  Orthostatic hypotension&#xD;
&#xD;
          -  Severe arrhythmia, unstable angina pectoris, acute myocardial infarction&#xD;
&#xD;
          -  Pregnancy 8. Alcoholism, substance abuse and drug addiction&#xD;
&#xD;
          -  Organic liver and kidney diseases with the development of functional disorders.&#xD;
&#xD;
          -  Anemia (hemoglobin &lt;10.5 g / dl for women and &lt;11.5 g / dl for men)&#xD;
&#xD;
          -  Active oncological process&#xD;
&#xD;
          -  Demyelinating and neurodegenerative diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Anna Bedenko, PhD student</last_name>
    <role>Principal Investigator</role>
    <affiliation>I.M. Sechenov First Moscow State Medical University (Sechenov University)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ludmila Antonenko, professor</last_name>
    <phone>89265774431</phone>
    <email>luda6917@yandex.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Bedenko, PhD student</last_name>
    <phone>89164989851</phone>
    <email>mailanna91@yandex.ru</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic of Neurology and Neurosurgery of I.M. Sechenov First Moscow State Medical University (Sechenov University)</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Bedenko, PhD student</last_name>
      <phone>+79164989851</phone>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <link>
    <url>https://www.elibrary.ru/author_items.asp?authorid=943018</url>
    <description>list of publications</description>
  </link>
  <reference>
    <citation>Bedenko A.S., Antonenko L.лю., Barinov A.N. Metabolic disorders in the pathogenesis of various causes of dizziness and instability // Annals of the Russian academy of medical sciences. - 2020. - Vol. 75. - N. 6. - P. 605-608. doi: 10.15690/vramn1244</citation>
  </reference>
  <reference>
    <citation>Bedenko A.S. Vertigo in neurological practice: rare causes and difficult decisions. Medical alphabet. 2019;2(19):34-36. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-19(394)-34-36</citation>
  </reference>
  <reference>
    <citation>Bedenko A.S. Metabolic factors in pathogenesis of migraine and unsteadiness. Medical alphabet. 2020;(33):18-20. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-18-20</citation>
  </reference>
  <results_reference>
    <citation>Bedenko A.S. Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy. Epilepsy and paroxysmal conditions. 2020;12(3):177-181. (In Russ.)https://doi.org/10.17749/2077-8333/epi.par.con.2020.032</citation>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Benign paroxysmal positional vertigo (BPPV)</keyword>
  <keyword>vestibular neuritis</keyword>
  <keyword>vestibular migraine</keyword>
  <keyword>central positional vertigo</keyword>
  <keyword>Meniere disease</keyword>
  <keyword>persistent postural-perceptual dizziness (PPPD)</keyword>
  <keyword>vitamin D deficiency</keyword>
  <keyword>hyperhomocysteinaemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vertigo</mesh_term>
    <mesh_term>Meniere Disease</mesh_term>
    <mesh_term>Benign Paroxysmal Positional Vertigo</mesh_term>
    <mesh_term>Vestibular Neuronitis</mesh_term>
    <mesh_term>Neuritis</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Dizziness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>I give my consent to provide actual study protocol. However, It is impossible to provide stastistical documents and primary patient's documentation (It is forbidden by Local Ethic Committee of Sechenov University)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

